DiaSorin Company Description
DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally.
It provides various immunodiagnostic in the areas, including infectious diseases, endocrinology, gastrointestinal infections, autoimmunity, hypertension, emergency/sepsis, bone metabolism, and oncology under LIAISON XL and LIAISON XS name.
The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens.
In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay.
Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
| Country | Italy |
| Founded | 1968 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 3,308 |
| CEO | Carlo Rosa |
Contact Details
Address: Via Crescentino snc Saluggia, Vercelli 13040 Italy | |
| Phone | 39 016 1487526 |
| Website | int.diasorin.com |
Stock Details
| Ticker Symbol | DSRLF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | IT0003492391 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Carlo Rosa | Chief Executive Officer, GM and Executive Director |
| Dr. Chen Menachem Even | Chief Commercial Officer, Senior Corporate Vice President of Commercial Operations and Executive Director |
| Piergiorgio Pedron | Senior Corporate Vice President, Chief Financial Officer and Corporate Accounting Documents Officer |
| Dr. Riccardo Fava | Corporate Vice President of Communication, ESG and Investor Relations |
| Ulisse Spada | Corporate Vice President, Head of the Legal Department, Secretary and General Counsel |
| Amelia Parente | Senior Corporate Vice President of Human Resources |
| Angelo Rago | President of Luminex Corporation |